- Home
- RDHL vs PAVM Comparison
RDHL vs PAVM Comparison
Compare RDHL & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RDHL | PAVM |
|---|---|---|
| Founded | 2009 | 2014 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9M | 9.3M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | RDHL | PAVM |
|---|---|---|
| Price | $1.19 | $0.33 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 69.6K | ★ 423.0K |
| Earning Date | 09-05-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,550,000.00 | $29,000.00 |
| Revenue This Year | $381.91 | N/A |
| Revenue Next Year | N/A | $450.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 157.62 | N/A |
| 52 Week Low | $1.01 | $0.30 |
| 52 Week High | $7.44 | $0.90 |
Technical Indicators
Market Signals| Indicator | RDHL | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 49.36 | 43.57 |
| Support Level | $1.18 | $0.32 |
| Resistance Level | $1.26 | $0.37 |
| Average True Range (ATR) | 0.05 | 0.03 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 78.00 | 25.00 |
Price Performance
Historical ComparisonAbout RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.